Analysed GLAUKOS CORP (GKOS:NYSE) News Sources
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
25-06-2026
yahoo.com
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
08-07-2026
yahoo.com
What is the current price of GLAUKOS CORP (GKOS:NYSE)?
The current price of GLAUKOS CORP (GKOS:NYSE) is $152.72.
GLAUKOS CORP (GKOS:NYSE) absolute price change since previous trading day?
The absolute price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is $-2.35.
GLAUKOS CORP (GKOS:NYSE) percentage price change since previous trading day?
The percentage price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is -1.5154%.
What is the most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE)?
The most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE) is 65 out of 100.
What is the most recent average sentiment for GLAUKOS CORP (GKOS:NYSE)?
The most recent sentiment for GLAUKOS CORP (GKOS:NYSE) is .
SEC-8K** Filing Available For GLAUKOS CORP (GKOS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.